299 related articles for article (PubMed ID: 30987631)
1. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D
BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
3. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
5. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
[TBL] [Abstract][Full Text] [Related]
6. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
7. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
Muthamilselvan S; Raghavendran A; Palaniappan A
PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
[TBL] [Abstract][Full Text] [Related]
8. Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer.
Lin K; Zhu X; Luo C; Bu F; Zhu J; Zhu Z
Immun Inflamm Dis; 2021 Mar; 9(1):167-182. PubMed ID: 33190424
[TBL] [Abstract][Full Text] [Related]
9. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
10. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.
Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX
Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
[TBL] [Abstract][Full Text] [Related]
15. Screening for differentially methylated genes among human colorectal cancer tissues and normal mucosa by microarray chip.
Chen W; Xiang J; Chen DF; Ni BB; Chen H; Fan XJ; Wang PN; Song SX; Fang LK; Xiao HY; Wang L; Wang JP
Mol Biol Rep; 2013 May; 40(5):3457-64. PubMed ID: 23471507
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide methylation and expression profiling identify methylation-associated genes in colorectal cancer.
Sun X; Chen D; Jin Z; Chen T; Lin A; Jin H; Zhu Y; Lai M
Epigenomics; 2020 Jan; 12(1):19-36. PubMed ID: 31833403
[No Abstract] [Full Text] [Related]
17. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
[TBL] [Abstract][Full Text] [Related]
18. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test.
Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
